Effectiveness of Dry Needling Versus Manual Trigger Point Release on Active Rhomboid Trigger Points

NCT ID: NCT07062692

Last Updated: 2025-07-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-23

Study Completion Date

2026-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study compares dry needling and manual trigger point release for treating active rhomboid trigger points in 48 patients, assessing pain, ROM, and function. It addresses a gap in evidence for optimal pain management in upper back myofascial pain. Findings will guide clinical practice for more effective, evidence-based interventions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This randomized controlled trial (RCT) investigates the effectiveness of dry needling versus manual trigger point release in treating active rhomboid trigger points. The study aims to compare the effect of two interventions on pain, range of motion (ROM), and functional outcomes in patients with rhomboid muscle pain.

Participants: 48 individuals (aged 20-60) with clinically confirmed active rhomboid trigger points.

Interventions:

Group 1: Dry needling therapy.

Group 2: Manual trigger point release. Both groups receive adjunct therapies (ultrasound, cold packs, and home exercises).

Outcome Measures: Pain (Numeric Pain Rating Scale), ROM (goniometer), and function (DASH Questionnaire).

Duration: 2-week intervention with follow-ups at 1 and 2 weeks.

Significance: The study addresses a gap in evidence for rhomboid trigger point treatments, guiding clinical decisions for pain management. Results may optimize therapeutic approaches for upper back pain.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Trigger Point Pain, Myofascial

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

dry needling trigger release therapy

This group will undergo dry needling trigger release therapy. Total of 2 sessions (one per week) followed by home based exercises plan. Treatment protocol of both groups will include Therapeutic ultrasound, Cold pack application and Home based exercise plan.

Group Type EXPERIMENTAL

dry needling trigger release therapy

Intervention Type OTHER

The dry needling intervention involved inserting sterile filiform needles directly into active rhomboid trigger points for 1-2 sessions (1 session/week) to elicit local twitch responses and relieve tension.

MANUAL TRIGGER POINT RELEASE

Manual trigger release will be given to the other group. Total of 2 sessions (one per week) followed by same home based exercises plan will be given to the both groups. Treatment protocol of both groups will include Therapeutic ultrasound, Cold pack application and Home based exercise plan.

Group Type EXPERIMENTAL

MANUAL TRIGGER POINT RELEASE

Intervention Type OTHER

The manual trigger point release intervention involved applying sustained pressure to active rhomboid trigger points followed by passive stretching to release muscle tension and improve mobility.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

dry needling trigger release therapy

The dry needling intervention involved inserting sterile filiform needles directly into active rhomboid trigger points for 1-2 sessions (1 session/week) to elicit local twitch responses and relieve tension.

Intervention Type OTHER

MANUAL TRIGGER POINT RELEASE

The manual trigger point release intervention involved applying sustained pressure to active rhomboid trigger points followed by passive stretching to release muscle tension and improve mobility.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Presence of a clinically confirmed active trigger point in the rhomboid muscle based on established criteria (e.g., palpable tight band, local tenderness, referred pain pattern).
* Pain Level: Moderate to severe pain intensity (e.g., 4 or higher on a Visual Analog Scale or Numeric Pain Rating Scale).
* Duration of Symptoms: pain for at least 4 weeks.

Exclusion Criteria

* Patient with conditions that may contribute to neck and subscapular pain other than rhomboid:
* fibromyalgia
* Rheumatic and inflammatory disease
* Recent Surgery
* Diabatic
* Cervical radiculopathy and nerve entrapment
* Pregnancy
* Malignancy
Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amna Anum, ms

Role: PRINCIPAL_INVESTIGATOR

Riphah International University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Riphah International University, Malakand

Chakdara, KPK, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Amna Anum, mS

Role: CONTACT

03324896605

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC-01017 Khaist Yousafzai

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.